Journalism of Courage
Advertisement
Prabha Raghavan
More From Prabha Raghavan - Page 2
Centre looks to finetuning vaccine strategy: studying single-shot effect to mixing dosesSubscriber Only
May 31, 2021 04:10 IST
Covishield, which is the main Covid vaccine in use in India, accounts for nearly 90 per cent of the 208.89 million doses administered since January 16.
Mon, May 31, 2021
Short on data, experts want India’s own vaccine effectiveness studySubscriber Only
May 27, 2021 03:00 IST
These findings emphasise India’s need to “urgently” conduct its own vaccine effectiveness studies.
Thu, May 27, 2021
Wockhardt offers to make 2 billion Covid vaccine doses a yearSubscriber Only
May 26, 2021 04:00 IST
Outside of India, Wockhardt already has an agreement with the UK government to “fill and finish” Covid-19 vaccines exclusively for the UK.
Wed, May 26, 2021
India, others push for TRIPS waiver scope beyond Covid vaccine at WTOSubscriber Only
May 23, 2021 06:59 IST
India is among 62 World Trade Organization (WTO) members that are pushing this draft, which limits the waiver period to three years, with a provision to review the duration.
Sun, May 23, 2021
Variant in India needs two vaccine doses for better safety: UK governmentSubscriber Only
May 23, 2021 04:58 IST
This sharply highlights the public health challenge in India as the B.1.617.2 begins to take over as the “dominant variant of concern” here and the country grapples with a severe shortage of vaccines.
Sun, May 23, 2021
90 crore doses per annum: Bharat Biotech says Covaxin set for a boostSubscriber Only
May 21, 2021 04:17 IST
The Hyderabad vaccine maker managed to touch a capacity of 20 million doses a month in April and was expecting to make around 30-35 million doses in May.
Fri, May 21, 2021
2-DG holds promise but need more data before use: ExpertsSubscriber Only
May 20, 2021 04:02 IST
2DG hasn’t been launched in the market and the price of the sachet hasn’t been announced. Many experts have flagged concerns over the approval.
Thu, May 20, 2021
After urging firms to make vaccines: Gadkari says was unaware govt started efforts to boost productionSubscriber Only
May 20, 2021 02:38 IST
“I was unaware that his ministry has started these efforts before I had given suggestion yesterday,” Gadkari tweeted, referring to Minister of State for Chemicals and Fertiliser Mansukh Mandaviya, who was present at the virtual conference where Gadkari made the remarks.
Thu, May 20, 2021
Short-supply Covid vaccines outliers in govt’s spirited price cap pushSubscriber Only
May 16, 2021 01:06 IST
India currently has just two Covid-19 vaccines in what is clearly a market overwhelmingly dominated by just one player.
Sun, May 16, 2021
Sputnik vaccine for Covid-19 unveiled in India: Rs 1,000 a shot, in cities by mid-JuneSubscriber Only
May 15, 2021 03:49 IST
At a little over Rs 995 per dose — not just for private hospitals but also for central and state governments — this will be the most expensive vaccine so far in the country’s mass immunisation programme.
Sat, May 15, 2021
Sputnik V now in India: What is the price of the Russian vaccine for Covid-19?Subscriber Only
May 14, 2021 14:28 IST
Sputnik V Covid-19 Vaccine: Sputnik V is a two-dose Covid-19 vaccine, which has an efficacy of over 91 per cent, according to a publication in scientific journal The Lancet. How much will it cost in India? How many doses will it add to India's vaccination efforts?
Thu, Jul 15, 2021
States float tenders but know it’s a long shot, say Centre’s job to buySubscriber Only
May 14, 2021 03:20 IST
Delhi wants to get 1 crore vaccine doses under the global tender but is also open to making a deal with manufacturers at its own level. Sisodia is, however, clear that the Centre should take responsibility in situations like Covid, a national disaster.
Fri, May 14, 2021
Explained: How phase 2/3 trials for Covaxin in 2-18 age group will be conductedSubscriber Only
May 13, 2021 13:01 IST
The trial is expected to study aspects like the safety of the vaccine in this age group, the kinds of adverse reactions it causes as well as the vaccine's ability to prompt an immune response.
Thu, May 13, 2021
Rs 700-Rs 1,500: Amid lack of clarity, what private hospitals are chargingSubscriber Only
May 11, 2021 04:16 IST
The variation in how these shots are priced between hospitals is currently around Rs 200-250.
Tue, May 11, 2021
How splitting vaccines 50-50 has created new supply bottlenecksSubscriber Only
May 10, 2021 03:00 IST
The logistics prior to May 1 leveraged the state-owned universal immunisation programme (UIP) infrastructure, which had a solid network of around 29,000 cold chain points across the country to store the vaccines at recommended temperatures.
Mon, May 10, 2021
Explained: Intellectual property waiver for Covid-19 vaccinesSubscriber Only
May 07, 2021 04:35 IST
The United States will pursue negotiations at WTO to waive intellectual property for Covid-19 vaccines. This can allow large-scale production in middle-income countries, but there are arguments against the move.
Tue, May 11, 2021
US backs IP rights waiver for Covid vaccines, EU says ready to discussSubscriber Only
May 07, 2021 04:05 IST
A waiver on IP protections would mean pharmaceutical firms and vaccine makers across the world can learn how to make these vaccines without fear of lawsuits from companies that originally developed them.
Fri, May 07, 2021
Uncertainty over vaccine supply as all 18-44 become eligible; big chains say we are readySubscriber Only
May 01, 2021 04:03 IST
On the eve of the scheduled opening of phase 3 of Covid-19 vaccinations covering the entire adult population of the country, the Centre said that only “some states” which have “co-ordinated” with vaccine makers on procuring from the open market, will begin the drive.
Sat, May 01, 2021
Behind shortage: vaccination surge in April and thinning buffer stocksSubscriber Only
May 01, 2021 02:10 IST
In April, India witnessed the highest demand for vaccines in a month with 90.50 million doses administered by 6.30 pm on Friday, more than the monthly production capacities of Covishield and Covaxin combined.
Sat, May 01, 2021
What rate card does not show: Govt help in developing CovaxinSubscriber Only
April 28, 2021 04:19 IST
According to Bharat Biotech, the firm will supply more than 50 percent of its production to the Centre at Rs 150 a dose. The higher rates for States and private hospitals are necessitated by its needs to fund R&D for other vaccines, the company said.
Wed, Apr 28, 2021
Serum Institute’s Rs 600/dose for Covishield in private hospitals is its highest rate the world overSubscriber Only
April 24, 2021 04:00 IST
This, despite it being contract-manufactured by Pune’s Serum Institute of India whose CEO Adar Poonawalla had said that the firm was making a profit even at a price of Rs 150 per dose.
Sun, Apr 25, 2021
Pfizer to offer vaccine to govt at ‘not-for-profit’ rateSubscriber Only
April 23, 2021 02:08 IST
The company's statement comes amid speculations that the US drug giant may sell its vaccines in open market now that the government has allowed vaccine-makers the option of setting their own prices for states and private hospitals.
Fri, Apr 23, 2021
Pfizer: Will supply Covid-19 vaccine only through government channelsSubscriber Only
April 22, 2021 04:06 IST
The decision by Pfizer comes at a time when India has opened up its immunisation strategy, and allowed companies the option of charging states and private hospitals a potentially higher rate for their vaccines.
Thu, Apr 22, 2021
Explained: India’s new Covid-19 vaccine policy from May 1Subscriber Only
April 22, 2021 03:30 IST
It seems certain that many recipients will pay more than in the first three phases of vaccination, but key questions about availability, distribution, prioritisation remain unanswered. Here's what is known so far.
Fri, Apr 30, 2021
Serum announces Covishield price, to make 10-crore doses a month by JulySubscriber Only
April 22, 2021 03:00 IST
Covishield vaccine price: The announcement comes two days after the central government decided to open up vaccinations against Covid-19 to those above the age of 18 years.
Thu, Apr 22, 2021Journalism of Courage
Install the Express App for
a better experience
a better experience
Featured
Trending Topics
News
Multimedia
Follow Us